Third, the small number of CAD patients, especially UA and CCS patients, might provide only limited information on the levels of sPD-L1 in CAD patients, and a study with a larger sample size is needed to confirm the usefulness of sPD-L1 for risk stratification in a different population. The gene discussed is SPDL1; the disease is coronary artery disorder.